Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Negro

Showing results (311-320 of 334) with videos related to

Pageof 34
Sort By:
Molecular Oncology|January 16, 2026
European Code Against Cancer, 5th edition - cancer-causing infections and related interventionsCatharina Johanna Alberts, Paul Bloem, Silvia de Sanjosé, et al.
Frontiers in Neurology|December 11, 2023
Electrophysiological neuromuscular alterations and severe fatigue predict long-term muscle weakness in survivors of COVID-19 acute respiratory distress syndromeMarco Benedini, Marta Cogliati, Tea Lulic-Kuryllo, et al.
Journal of Hepatology|August 6, 2005
International, multicenter, randomized, controlled study comparing dynamically individualized versus standard treatment in patients with chronic hepatitis CStefan Zeuzem, Jean-Michel Pawlotsky, Esther Lukasiewicz, et al.
Plos One|July 19, 2012
A genetic validation study reveals a role of vitamin D metabolism in the response to interferon-alfa-based therapy of chronic hepatitis CChristian M Lange, Stephanie Bibert, Zoltan Kutalik, et al.
Infectious Diseases and Therapy|June 14, 2021
Real-World Outcomes in Historically Underserved Patients with Chronic Hepatitis C Infection Treated with Glecaprevir/PibrentasvirAlessio Aghemo, Yves Horsmans, Stefan Bourgeois, et al.
Gastroenterology|May 16, 2006
Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient dataGioacchino Leandro, Alessandra Mangia, Jason Hui, et al.
Swiss Medical Weekly|July 9, 2024
Real-life experience of chronic hepatitis C treatment in Switzerland: a retrospective analysisEleni Moschouri, Gloria Salemme, Adriana Baserga, et al.
Nature Communications|December 24, 2014
Reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genesEwa Terczyńska-Dyla, Stephanie Bibert, Francois H T Duong, et al.
Gastroenterology|October 9, 2007
HCV-specific T-cell response in relation to viral kinetics and treatment outcome (DITTO-HCV project)Massimo Pilli, Alessandro Zerbini, Amalia Penna, et al.
Hepatology (Baltimore, Md.)|August 29, 2018
Deficient Natural Killer Cell NKp30-Mediated Function and Altered NCR3 Splice Variants in Hepatocellular CarcinomaStefania Mantovani, Barbara Oliviero, Andrea Lombardi, et al.
Pageof 34

Showing results (311-320 of 334) with videos related to

Sort By:
Pageof 34
Molecular Oncology|January 16, 2026
European Code Against Cancer, 5th edition - cancer-causing infections and related interventionsCatharina Johanna Alberts, Paul Bloem, Silvia de Sanjosé, et al.
Frontiers in Neurology|December 11, 2023
Electrophysiological neuromuscular alterations and severe fatigue predict long-term muscle weakness in survivors of COVID-19 acute respiratory distress syndromeMarco Benedini, Marta Cogliati, Tea Lulic-Kuryllo, et al.
Journal of Hepatology|August 6, 2005
International, multicenter, randomized, controlled study comparing dynamically individualized versus standard treatment in patients with chronic hepatitis CStefan Zeuzem, Jean-Michel Pawlotsky, Esther Lukasiewicz, et al.
Plos One|July 19, 2012
A genetic validation study reveals a role of vitamin D metabolism in the response to interferon-alfa-based therapy of chronic hepatitis CChristian M Lange, Stephanie Bibert, Zoltan Kutalik, et al.
Infectious Diseases and Therapy|June 14, 2021
Real-World Outcomes in Historically Underserved Patients with Chronic Hepatitis C Infection Treated with Glecaprevir/PibrentasvirAlessio Aghemo, Yves Horsmans, Stefan Bourgeois, et al.
Gastroenterology|May 16, 2006
Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient dataGioacchino Leandro, Alessandra Mangia, Jason Hui, et al.
Swiss Medical Weekly|July 9, 2024
Real-life experience of chronic hepatitis C treatment in Switzerland: a retrospective analysisEleni Moschouri, Gloria Salemme, Adriana Baserga, et al.
Nature Communications|December 24, 2014
Reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genesEwa Terczyńska-Dyla, Stephanie Bibert, Francois H T Duong, et al.
Gastroenterology|October 9, 2007
HCV-specific T-cell response in relation to viral kinetics and treatment outcome (DITTO-HCV project)Massimo Pilli, Alessandro Zerbini, Amalia Penna, et al.
Hepatology (Baltimore, Md.)|August 29, 2018
Deficient Natural Killer Cell NKp30-Mediated Function and Altered NCR3 Splice Variants in Hepatocellular CarcinomaStefania Mantovani, Barbara Oliviero, Andrea Lombardi, et al.
Pageof 34